Skip to main content
Clinical Trials/NCT06439420
NCT06439420CompletedPhase 2

Cognitive Behavioral Therapy for Insomnia in Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial

Virginia Commonwealth University2 sites in 1 country70 target enrollmentStarted: July 8, 2024Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
70
Locations
2
Primary Endpoint
Rate of baseline assessment completion

Study Overview

Brief Summary

This study seeks to investigate an evidence-based, manualized, behavioral health intervention, Cognitive Behavioral Therapy for Insomnia (CBT-I), in individuals with primary brain tumors (PBT) and insomnia. Our project will assess the feasibility and acceptability of recruitment, enrollment, data collection procedures, and retention of individuals with PBT and insomnia in the behavioral health intervention, CBT-I, and investigate the potential benefits of CBT-I within this at-risk and understudied population. In the long term, the goals are to expand treatment options for neuro-oncology patients and improve their mission readiness and overall wellbeing.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Primary brain tumor diagnosis (grade I-IV)
  • >/=2weeks post-cranial resection (if applicable)
  • >/=1 month post-radiation therapy (if applicable)
  • Able to understand, speak, and read English
  • Absence of major cognitive concerns
  • Meet Diagnostic and statistical manual of mental disorders version 5 (DSM-V) diagnostic criteria for insomnia
  • Reliable internet connection

Exclusion Criteria

  • Major communication difficulties that would prohibit effective intervention
  • Inability to attend weekly virtual group meetings
  • Inability to understand and provide informed consent
  • Currently a prisoner or residing in a correctional facility

Outcomes

Primary Outcomes

Rate of baseline assessment completion

Time Frame: Week 1

Number of participants that complete the baseline assessment

Rate of consent to screening procedures

Time Frame: Baseline (Day 1)

Number of participants that consent to screening procedures

Rate of post-intervention assessment completion

Time Frame: Week 6

The number of participants that complete the post-intervention assessment

Acceptability of quantity of assessments

Time Frame: Week 18

Satisfaction rating of quantity of assessments on a scale of 1-5 with 5 being the best

Rate of intervention attrition

Time Frame: Week 6

The number of participants that do not complete the CBT-I intervention

Rate of those eligible enrolling

Time Frame: Baseline (Day 1)

Number of participants that are eligible to enroll to the protocol

Rate of follow-up assessment completion

Time Frame: Week 18

The number of participants that complete the follow-up assessment

Acceptability of timing of assessments

Time Frame: Week 18

Satisfaction ratings of timing of assessments on a scale of 1-5 with 5 being the best

Acceptability of duration of assessments

Time Frame: Week 18

Satisfaction ratings of duration of assessments on a scale of 1-5 with 5 being the best

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

CBT-I in Primary Brain Tumor Patients:... | Clinical Trial